Rating History for Lyra Therapeutics (LYRA) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for LYRA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/7/2024 Jason Gerberry Downgrade Underperform
(Buy)		 0.35
(N/A)		 0.52
(0.50)		 -3.85% Details